Among 135 with complete primary end-point data , the ovarian failure rate was 8 % in the goserelin group and 22 % in the chemotherapy-alone group ( odds ratio , 0.30 ; 95 % confidence interval [ CI ] , 0.09 to 0.97 ; two-sided P = 0.04 ) .